Detection of Chlamydia trachomatis and Neisseria gonorrhoeae based on cross-priming amplification

被引:9
|
作者
Yu, B. [1 ]
An, Y. [2 ]
Xu, G. [3 ]
Shan, H. [4 ]
机构
[1] Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med, Dept Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China
[2] Yulin City First Hosp, Dept Gastroenterol, Xian, Shaanxi, Peoples R China
[3] Univ Glasgow, Sch Engn, Div Biomed Engn, Glasgow, Lanark, Scotland
[4] Adicon Clin Labs, 398 Tianmushan Rd, Hangzhou, Zhejiang, Peoples R China
关键词
cross-priming amplification; cross-contamination proof device; disposable amplicon detection; polymerase chain reaction; resource-limited area; sexually transmitted disease; RESOURCE-LIMITED SETTINGS; INFECTIONS; TESTS; PCR;
D O I
10.1111/lam.12560
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Rapid, sensitive and specific isothermal nucleic acid amplification methods of Chlamydia trachomatis (C.trachomatis) and Neisseria gonorrhoeae (N.gonorrhoeae) have been developed based on cross-priming amplification (CPA). The amplicon of CPA can be detected by a disposable amplicon cross-contamination proof device. The whole assay takes 1-15h from amplification to read out. Ten fold serial dilutions of quantified plasmids were used to test the CPA assay sensitivities, with the detection limits of 45 copies per reaction and 65 copies per reaction for C.trachomatis and N.gonorrhoeae respectively. The specificities of CPA assays for C.trachomatis and N.gonorrhoeae were tested by using total DNA extracted from nine other bacterial strains, and no cross-reactivity was detected. Eighty clinical cervical or vaginal swab specimens were tested by both CPA and real-time polymerase chain reaction (PCR) with the consistencies of 9875% (79/80) and 975% (78/80) for C.trachomatis and N.gonorrhoeae respectively. Using real-time PCR as a reference standard, the clinical sensitivity (positive) and specificity (negative) of CPA was found to be 9815% (53/54) and 100% (26/26) for C.trachomatis, and 9375% (30/32) and 100% (48/48) for N.gonorrhoeae. Eight swab specimens tested positive for both C.trachomatis and N.gonorrhoeae simultaneously by real-time PCR and CPA assay. This study demonstrated that CPA is an affordable and accessible assay for C.trachomatis and N.gonorrhoeae detection, with high sensitivity and specificity. Significance and Impact of the StudyRapid and specific detection of the sexually transmitted pathogens Chlamydia trachomatis (C.trachomatis) and Neisseria gonorrhoeae (N.gonorrhoeae) would enable early treatment and management of their spread. Here, for the first time, a user friendly DNA isothermal amplification method named cross-priming amplification (CPA), was used to test C.trachomatis and N.gonorrhoeae with high sensitivity and specificity. The results indicate that CPA has great potential for improving C.trachomatis and N.gonorrhoeae diagnostics which could be particularly advantageous in resource-limited areas.
引用
收藏
页码:399 / 403
页数:5
相关论文
共 50 条
  • [1] Performance of strand displacement amplification assay in the detection of Chlamydia trachomatis and Neisseria gonorrhoeae
    Fontana, C
    Favaro, M
    Cicchetti, O
    Minelli, S
    Pistoia, ES
    Favalli, C
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2005, 58 (05) : 283 - 288
  • [2] Multiplex Strand Invasion Based Amplification (mSIBA) assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae
    Kevin E. Eboigbodin
    Mark J. Hoser
    Scientific Reports, 6
  • [3] Multiplex Strand Invasion Based Amplification (mSIBA) assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae
    Eboigbodin, Kevin E.
    Hoser, Mark J.
    SCIENTIFIC REPORTS, 2016, 6
  • [4] Detection of Neisseria gonorrhoeae and Chlamydia trachomatis infections in pregnant women by multiplex recombinase polymerase amplification
    Zhai, Jingjing
    Wang, Limin
    Qiao, Xiaoliang
    Zhao, Jianping
    Wang, Xuexia
    He, Xiaohong
    PLOS ONE, 2021, 16 (05):
  • [5] Multiplex isothermal helicase-dependent amplification assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae
    Doseeva, Victoria
    Forbes, Thomas
    Wolff, John
    Khripin, Yuri
    O'Neil, Dominic
    Rothmann, Thomas
    Nazarenko, Irina
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2011, 71 (04) : 354 - 365
  • [6] Molecular diagnostic methods for the detection of Neisseria gonorrhoeae and Chlamydia trachomatis
    Hall, GS
    REVIEWS IN MEDICAL MICROBIOLOGY, 2005, 16 (02) : 69 - 77
  • [7] Detection of Neisseria gonorrhoeae and Chlamydia trachomatis colonization of the gravid cervix
    Asbill, KK
    Higgins, RV
    Bahrani-Mostafavi, Z
    Vachris, JC
    Kotrotsios, SH
    Elliot, MC
    Price, DK
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (02) : 340 - 344
  • [8] APTIMA® transcription-mediated amplification assays for Chlamydia trachomatis and Neisseria gonorrhoeae
    Chernesky, Max A.
    Jang, Dan E.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2006, 6 (04) : 519 - 525
  • [9] Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by strand displacement amplification and relevance of the amplification control for use with vaginal swab specimens
    Cosentino, LA
    Landers, DV
    Hillier, SL
    JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (08) : 3592 - 3596
  • [10] Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three nucleic acid amplification tests
    Van Dyck, E
    Ieven, M
    Pattyn, S
    Van Damme, L
    Laga, M
    JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (05) : 1751 - 1756